Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – C-o-group doai
Patent
1996-05-31
1998-01-13
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
C-o-group doai
514547, A61K 3105, A61K 31225
Patent
active
057080372
ABSTRACT:
Polyprenyl derivatives having the general formula as the active ingredient: ##STR1## where R.sup.1 and R.sup.2 are the same or different, and each represents a hydrogen atom, a C.sub.1 -C.sub.4 alkyl group, a C.sub.2 -C.sub.12 aliphatic acyl group, a C.sub.7 -C.sub.11 aromatic acyl group or a C.sub.8 -C.sub.12 aryl-substituted aliphatic acyl group; and n represents an integer from 0 to 2, show excellent activity in the inhibition of the formation of inflammatory cytokines, and they exhibit an excellent therapeutic effect on inflammatory bowel diseases such as ulcerative colitis, Crohn's disease and Behcet syndrome.
REFERENCES:
patent: 4192953 (1980-03-01), Mishima et al.
patent: 4434179 (1984-02-01), Kobayashi et al.
Henley III Raymond
Sankyo Company Limited
LandOfFree
Inhibitor of inflammatory cytokine formation comprising polypren does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitor of inflammatory cytokine formation comprising polypren, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitor of inflammatory cytokine formation comprising polypren will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-326817